Functional Foods Deliver GI Benefits References

Functional Foods Deliver GI Benefits References

1. Mindell, Earl. Users Guide to Probiotics. North Bergen, NJ.: BasicHealth Publications Inc., 2004.

2. Valeur N et al. Colonization and immunomodulation by Lactobacillusreuteri ATCC 55730 in the human gastrointestinal tract. Appl EnvironMicrobiol. 70, 2:1176-81, 2004. www.aem.asm.org

3. Turchet P et al. Effect of fermented milk containing the probioticLactobacillus casei DN-114001 on winter infections in free-living elderlysubjects: a randomised, controlled pilot study. J Nutr Health Aging.7, 2:75-7, 2003. www.serdi-fr.com/jnha

4. Nopchinda S et al. Effect of bifidobacterium Bb12 with or withoutStreptococcus thermophilus supplemented formula on nutritional status. JMed Assoc Thai. 85 Suppl 4:S1225-31, 2002. http://www.medassocthai.org/journal/all.php

5. Sudarmo SM et al. Management of infant diarrhea with high-lactoseprobiotic-containing formula. Southeast Asian J Trop Med Public Health.34, 4:845-8, 2003. www.ams.cmu.ac.th/lib/toc.htm

6. Gaon D et al. Effect of Lactobacillus strains (L. casei and L.Acidophillus Strains cerela) on bacterial overgrowth-related chronic diarrhea.Medicina (B Aires). 62, 2:159-63, 2002. www.medicinabuenosaires.com/index2.htm

7. Koebnick C et al. Probiotic beverage containing Lactobacillus caseiShirota improves gastrointestinal symptoms in patients with chronicconstipation. Can J Gastroenterol. 17, 11:655-9, 2003. www.pulsus.com/Gastro/home2.htm

8. Kim HJ et al. A randomized controlled trial of a probiotic, VSL#3, ongut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. AlimentPharmacol Ther. 17, 7:895-904, 2003. www.blackwellpublishing.com/journal.asp?ref=0269-2813

9. Ahola AJ et al. Short-term consumption of probiotic-containing cheeseand its effect on dental caries risk factors. Arch Oral Biol. 47,11:799-804, 2002. www.sciencedirect.com/science/journal/00039969

10. Fedorak RN et al. Probiotics and the management of inflammatory boweldisease. Inflamm Bowel Dis. 10, 3:286-99, 2004. www.lww.com/product/?1078-0998

11. Mimura T et al. Once daily high dose probiotic therapy (VSL#3) formaintaining remission in recurrent or refractory pouchitis. Gut. 53,1:108-14, 2004. http://gut.bmjjournals.com

12. Gionchetti P et al. Prophylaxis of pouchitis onset with probiotictherapy: a double-blind, placebo-controlled trial. Gastroenterology.124, 5:1202-9, 2003. www2.gastrojournal.org

13. Gionchetti P et al. Oral bacteriotherapy as maintenance treatment inpatients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology.119, 2:305-9, 2000. www2.gastrojournal.org

14. Guslandi M et al. A pilot trial of Saccharomyces boulardii inulcerative colitis. Eur J Gastroenterol Hepatol. 15, 6:697-8, 2003. www.eurojgh.com

15. Henker J et al. Successful treatment of gut-caused halitosis with asuspension of living non-pathogenic Escherichia coli bacteria--a case report.Eur J Pediatr. 160, 10:592-4, 2001. http://link.springer.de/link/service/journals/00431

16. Ahola AJ et al. Short-term consumption of probiotic-containing cheeseand its effect on dental caries risk factors. Arch Oral Biol. 47,11:799-804, 2002. www.sciencedirect.com/science/journal/00039969

17. Nase L et al. Effect of long-term consumption of a probioticbacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries riskin children. Caries Res. 35, 6:412-20, 2001. http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=224219

18. Linsalata M et al. The influence of Lactobacillus brevis on ornithinedecarboxylase activity and polyamine profiles in Helicobacter pylori-infectedgastric mucosa. Helicobacter. 9, 2:165-72, 2004. http://www.blackwellpublishing.com/journal.asp?ref=1083-4389

19. Reid G et al. Oral use of Lactobacillus rhamnosus GR-1 and L.fermentum RC-14 significantly alters vaginal flora: randomized,placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol.35, 2:131-4, 2003. http://www.sciencedirect.com/science/journal/09288244

20. Guslandi M et al. A pilot trial of Saccharomyces boulardii inulcerative colitis. Eur J Gastroenterol Hepatol. 15, 6:697-8, 2003. www.eurojgh.com

21. Kim HJ et al. A randomized controlled trial of a probiotic, VSL#3, ongut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. AlimentPharmacol Ther. 17, 7:895-904, 2003. http://www.blackwellpublishing.com/journal.asp?ref=0269-2813

22. Mimura T, et al. Once daily high dose probiotic therapy (VSL#3) formaintaining remission in recurrent or refractory pouchitis. Gut. 2004Jan;53(1):108-14. http://gut.bmjjournals.com

23. Gaon D et al. Effect of Lactobacillus strains and Saccharomycesboulardii on persistent diarrhea in children. Medicina (B Aires). 63,4:293-8, 2003. www.medicinabuenosaires.com/index2.htm

24. Koebnick C et al. Probiotic beverage containing Lactobacillus caseiShirota improves gastrointestinal symptoms in patients with chronicconstipation. Can J Gastroenterol. 17, 11:655-9, 2003. www.pulsus.com/Gastro/home2.htm

25. Kanauchi O et al. Modification of intestinal flora in the treatment ofinflammatory bowel disease. Curr Pharm Des. 9, 4:333-46, 2003. www.bentham.org/cpd

26. Hopkins MJ et al. Nondigestible oligosaccharides enhance bacterialcolonization resistance against Clostridium difficile in vitro. ApplEnviron Microbiol. 69, 4:1920-7, 2003. http://aem.asm.org

27. Kanauchi O et al. Modification of intestinal flora in the treatment ofinflammatory bowel disease. Curr Pharm Des. 9, 4:333-46, 2003. www.bentham.org/cpd

28. Roberfroid M. Functional food concept and its application toprebiotics. Dig Liver Dis. 34 Suppl, 2:S105-10, 2002. http://authors.elsevier.com/JournalDetail.html?PubID=623449&Precis=DESC

29. Pereira DI et al. Effects of consumption of probiotics and prebioticson serum lipid levels in humans. Crit Rev Biochem Mol Biol. 37,4:259-81, 2002. www.sciencedirect.com/science/journal/10409238

30. Wisker 0E. [Probiotics] Zentralbl Gynakol. 125, 12:475-9,2003.

31. Cashman K. Prebiotics and calcium bioavailability. Curr IssuesIntest Microbiol. 4, 1:21-32, 2003. www.ciim.net

32. Orafti NV et al. Prebiotics promote good health: the basis, thepotential, and the emerging evidence. J Clin Gastroenterol. 38, (6Suppl):S70-5, 2004. www.jcge.com

33. Dai D et al. Protective nutrients and bacterial colonization in theimmature human gut. Adv Pediatr. 46:353-82, 1999.